Pontifax Management 4 G.P. (2015) Ltd. Insider Trading Activity

Average Profitability
51.74%
Insider Buys Quantity
2
Insider Buys Sum
$20M
Insider Sells Quantity
0
Insider Sells Sum
$0

Insider Activity of Pontifax Management 4 G.P. (2015) Ltd.

Biography of Pontifax Management 4 G.P. (2015) Ltd.

No biography is available at this moment.

2025-10-15SaleKeros Therapeutics, Inc.
KROS
10 percent owner
155,262
0.4683%
$17.75$2.76M-20.08%
2021-05-13PurchaseEloxx Pharmaceuticals, Inc.
ELOX
10 percent owner
5.93M
7.0883%
$1.35$8M-27.06%
2020-11-17PurchaseKeros Therapeutics, Inc.
KROS
10 percent owner
120,000
0.5794%
$50.00$6M-19.24%
2020-04-13PurchaseKeros Therapeutics, Inc.
KROS
10 percent owner
874,998
3.4196%
$16.00$14M+122.73%
2019-06-24PurchaseEloxx Pharmaceuticals, Inc.
ELOX
10 percent owner
200,000
0.5562%
$9.00$1.8M-52.66%
2018-04-30PurchaseEloxx Pharmaceuticals, Inc.
ELOX
10 percent owner
350,000
0.8739%
$9.75$3.41M+10.18%
2018-03-22PurchaseEloxx Pharmaceuticals, Inc.
ELOX
10 percent owner
6,000
0.0213%
$8.00$48,000+65.44%
2018-03-21PurchaseEloxx Pharmaceuticals, Inc.
ELOX
10 percent owner
6,600
0.0231%
$7.55$49,830+72.29%
Total: 8
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.